Clinical Research Facility

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Cystic fibrosis2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Vertex Pharmaceuticals Incorporated2 trials

Running trials

• Active, not recruiting

  A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

  NCT05444257· Phase 3· Vertex Pharmaceuticals Incorporated· Source

Closed trials

• Completed

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· Phase 3· Vertex Pharmaceuticals Incorporated· Source